| Vol. 15.08 – 3 March, 2023 |
| |
|
|
| The authors showed by multiple redundant and complementary methods that tingible body macrophages derived from a lymph node-resident, CD169-lineage, CSF1R-blockade-resistant precursor that was prepositioned in the lymphoid follicle. [Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators performed a genome-scale screen to discover alternative pathways for T cell-mediated killing of MHC class I deficient tumor cells, and carried out further mechanistic studies demonstrating that inhibition of autophagy amplified pro-apoptotic effects of cytokines in tumor cells. [Cancer Discovery] |
|
|
|
| Researchers investigated whether lymphatic vessel-mediated effector CD8+ T cell egress limited the accumulation of a broad repertoire of functional CD8+ T cells. [Nature Immunology] |
|
|
|
| Using murid herpesvirus 4, a mouse gammaherpesvirus, scientists showed that after infection, lung-resident and recruited group 2 innate lymphoid cells exhibited a reduced ability to expand and produce type 2 cytokines in response to house dust mites, thereby contributing to protection against asthma. [Science Immunology] |
|
|
|
| Mechanistically, itaconate suppressed glycolysis and oxidative phosphorylation in T helper 17- and Treg-polarizing T cells. [Nature Communications] |
|
|
|
| Using lupus-prone mice, researchers demonstrated that genetic disruption or pharmacologic inhibition of NFAT signaling specifically impacted follicular helper T cell maintenance and lead to amelioration of autoantibody production and renal injury. [Journal Of Experimental Medicine] |
|
|
|
| Depleting B cells via anti-CD20 in a mouse model of multiple sclerosis unleashed the activity of myeloid cells and microglia and accelerated disease severity, while adoptive transfer of IL-10-providing B cells restored in vivo control of central nervous system macrophages and microglia. [Acta Neuropathologica] |
|
|
|
| Researchers investigated the activation of remodeling pathways within the macrophage population when peripheral nerve injury repair was delayed, and identified alteration of key upstream regulators of the inflammatory response. [Npj Regenerative Medicine] |
|
|
|
| The coinjection of pericyte stem cells and tumor epithelial cells led to increased tumor growth, differentiation of Ly6G+ myeloid-derived suppressor cells, and a decreased amount of F4/80+ macrophages and CD11c+ dendritic cells. [EMBO Reports] |
|
|
|
|
| Scientists discuss recent data and concepts suggesting that the biology of myeloid cells is largely defined by a very limited number of functional states that transcend the narrowly defined cell populations. [Cancer Cell] |
|
|
|
| The authors review the evidence and efficacy of current treatments for systemic sclerosis, and highlight key areas where further research to better understand and treat the disease is necessary. [Nature Reviews Rheumatology] |
|
|
|
|
| Regeneron Pharmaceuticals, Inc. and Sanofi announced that the US FDA has approved Kevzara® for the treatment of polymyalgia rheumatica, an inflammatory rheumatic disease, in adult patients who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. [Regeneron Pharmaceuticals, Inc.] |
|
|
|
|
| April 16 – 19, 2023 Snowbird, Utah, United States |
|
|
|
|
|
| University of Cambridge – Cambridge, England, United Kingdom |
|
|
|
| Beth Israel Deaconess Medical Center – Boston, Massachusetts, United States |
|
|
|
| Karolinska Institutet – Solna, Sweden |
|
|
|
| The University of Melbourne – Melbourne, Australia |
|
|
|
| Cornell University – Ithaca, New York, United States |
|
|
|
|